Anant Mohan

TL;DR: The findings from the studies on serum/plasma DNA suggest that it would be possible to develop a simple blood test with high sensitivity and specificity that has potential for screening of high-risk individuals, for prognostic or staging purposes, and to be used as intermediate end-points of efficacy in chemo-prevention and therapeutic trials.

TL;DR: A systematic review calculated the prevalence of respiratory viral infections in AECOPD and found that viruses are important aetiological agents of acute exacerbation of COPD.

TL;DR: The development of biomarkers in cancer research and detection is described with emphasis on different proteomic tools for the identification and discovery of new biomarkers, different clinical assays to detect various biomarker in different specimens, role of biomarkering in cancer screening and last but not the least, the challenges in this direction of cancer research.

TL;DR: Manipulation of PD-1 signaling may restore the host T-cell response and thus may have therapeutic potential and also may serve as a biomarker to monitor host immunity among patients with tuberculosis during therapy and vaccine studies.

TL;DR: The results do not support the concern that antioxidants might protect cancer cells from the free radical damage induced by chemotherapy, and larger trials are needed to demonstrate whether high-dose multiple antioxidants in conjunction with chemotherapy increase the response rates and/or survival time in advanced lung cancer.